# Clinical Trial to Evaluate the Efficacy and Safety of Platelet-rich Plasma Infiltration in Chronic Omalgia

> **NCT07448285** · PHASE3 · RECRUITING · sponsor: **Biobizkaia Health Research Institute** · enrollment: 86 (estimated)

## Conditions studied

- Chronic Pain

## Interventions

- **BIOLOGICAL:** Platelet-rich Plasma Local injection
- **DRUG:** betamethasone and Ropivacaine

## Key facts

- **NCT ID:** NCT07448285
- **Lead sponsor:** Biobizkaia Health Research Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2029-02
- **Final completion:** 2029-04
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07448285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07448285, "Clinical Trial to Evaluate the Efficacy and Safety of Platelet-rich Plasma Infiltration in Chronic Omalgia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07448285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*